Clonal stability in late-relapsing childhood lymphoblastic leukaemia

Area of Science:

• Hematology
• Oncology
• Immunology

Background:

• Childhood acute lymphoblastic leukemia (ALL) is a common pediatric cancer.
• Long-term remission and cure are primary goals in ALL treatment.
• Understanding disease persistence mechanisms is crucial for improving outcomes.

Observation:

• A case of childhood ALL relapsed 17 years after initial therapy.
• The immunoglobulin heavy chain (IgH) gene rearrangement was analyzed in diagnostic and relapse samples.
• Polymerase chain reaction and direct sequencing were used to assess clonal stability.

Findings:

• The clonal IgH gene rearrangement demonstrated remarkable stability over 17 years.
• Complete sequence homology was confirmed between diagnostic and relapse samples.
• No significant clonal evolution was detected, indicating genetic persistence.

Implications:

• Persistent minimal residual disease may underlie late relapses in ALL.
• Effective immune surveillance could be critical for controlling residual leukemia cells.
• This highlights the importance of long-term monitoring and understanding immune system roles in ALL cure.